← SynDRA
NAVARIXIN ANHYDROUS
SynDRA canonical compound SYN0006422 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | CXCR2 |
| Mechanism of action | CCK receptor antagonist |
All known targets
Mechanisms of action (all sources)
- CCK receptor antagonist
- CXCR2 ANTAGONIST
- Interleukin-8 receptor B antagonist
- CXCR1 ANTAGONIST
- Interleukin-8 receptor A antagonist
- CC chemokine receptor antagonist
- CXCR2 MODULATOR
Cross-references
Synonyms
- Navarixin (anhydrous)
- Navarixine
- Navarixina
- MK-7123
- MK7123
- SCH 527123
- SCH527123
- Navarixin
- Sch527123
- (R)-2-Hydroxy-N,N-dimethyl-3-((2-((1-(5-methylfuran-2-yl)propyl)amino)-3,4-dioxocyclobut-1-en-1-yl)amino)benzamide
- CHEMBL216981
- (R)-2-hydroxy-N,N-dimethyl-3-(2-(1-(5-methylfuran-2-yl)propylamino)-3,4-dioxocyclobut-1-enylamino)benzamide
- SCHEMBL184744
- GTPL8497
- KS-00001CQK
- CTK8B8735
- MolPort-023-331-228
- BDBM50200880
- ANW-61143
- ZINC100033051
- AKOS016003539
- CS-0609
- NCGC00390675-01
- HY-10198
- AX8217127
- TC-149888
- W-5650
- SCH 527123,CAS:473727-83-2
- PF-00547659
- navarixin
- EX-A4879
- YTA72783
- s8506
- CXCR2 Antagonist IV, Sch527123
- AT10795
- 2-hydroxy-N,N-dimethyl-3-[[2-[[(1R)-1-(5-methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobuten-1-yl]amino]benzamide
- AC-33600
- BS-17324
- A917603
Look up NAVARIXIN ANHYDROUS in the interactive SynDRA portal →